ຕົວຍັບຍັ້ງພູມຕ້ານທານແມ່ນປະເພດຢາທີ່ຕໍ່ສູ້ກັບລະບົບພູມຕ້ານທານຂອງຮ່າງກາຍເພື່ອຕໍ່ສູ້ກັບຈຸລັງມະເຮັງ. ຢ່າງໃດກໍຕາມ, ຄົນເຈັບສ່ວນໃຫຍ່ບໍ່ຕອບສະຫນອງຕໍ່ການປິ່ນປົວເຫຼົ່ານີ້. ມີຢາຊະນິດໃໝ່ກວ່າທີ່ແນໃສ່ໂປຣຕີນ 2 ຊະນິດທີ່ກ່ຽວຂ້ອງກັບການສະກັດກັ້ນການຕອບສະໜອງຂອງພູມຄຸ້ມກັນຂອງຮ່າງກາຍຕໍ່ກັບເນື້ອງອກ.
Phase I of clinical trials has shown some exciting results, which were conducted in 19 patients suffering from ມະເຮັງ with the molecule M7824. These researchers are also undertaking trials with those suffering from ມະເລັງກະເພາະອາຫານ and those infected with HPV.
There are many other trials and experiments being taken to treat and ປິ່ນປົວມະເຮັງ more effectively in different research institutes. This drug with a dual approach will be a boon in the ການປິ່ນປົວມະເຮັງ, as with a single molecule, multiple therapies are included.